Chronic liver disease is surging in the US and no group is more affected than Asians and Pacific Islanders. Find out how Dr. Tomoaki Kato and Columbia Liver Asian Outreach is addressing this problem.
Almost all liver cancers develop after decades of chronic liver disease, but a new discovery by Columbia researchers, led by Robert Schwabe, MD, may lead to treatments that could break the link.